Optimal threshold for stromal tumor-infiltrating lymphocytes
Its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy
Its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy
Head and Neck Pathol (2016) 10:75–84 DOI 10.1007/s12105-016-0695-8